Hayden Malone: Ongoing efforts to target chromatin remodellers in cancer

Hayden Malone, PhD Candidate at St. Jude Children’s Research Hospital, shared a post on LinkedIn:

”Delighted to share my first first-author manuscript published in Nature Reviews Drug Discovery. In this Review, Charles Roberts and I discuss ongoing efforts to target chromatin remodellers in cancer and other diseases, with a focus on SWI/SNF complexes. We also discuss efforts to leverage other synthetic lethalaties to treat the approximately 20% of all cancers that have mutations in SWI/SNF subunits.”

Chromatin remodellers as therapeutic targets.

Authors: Hayden A. Malone, Charles W. M. Roberts.

Source: Hayden Malone/LinkedIn